Delivery Order SPE2DB22D3301-SPE2DB25FX9TA
Award Date 2/6/25
Potential Completion Date 2/7/25
Potential Value $30K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,740.45 firm fixed price delivery order is for the supply of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a medication used for the treatment of diabetes. The contract has an ultimate completion date of January 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,292.59, is for the delivery of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a pharmaceutical product, and has an ultimate completion date of April 14, 2025. This appears to be a delivery order issued under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIRAGLUTIDE 2-PAK 18 MG/3 ML 3ML, a pharmaceutical product, with a ceiling value of $21,763.15. The contract is a Firm Fixed Price Delivery Order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,501.82, is for the delivery of Liraglutide 2-pak 18 mg/3 ml 3 ml, a medication used to treat diabetes. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of January 21, 2025. The contract does not have a set-aside designation, indicating open...
- This federal contract award, valued at $26,405.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a pharmaceutical product used in the treatment of diabetes. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,739.88, is for the delivery of a quantity of 3-pack, 18 mg/3 ml liraglutide medication. The contract has a firm fixed price pricing type and an ultimate completion date of February 10, 2025. The contract is not designated with a set-aside requirement. AmerisourceBergen Drug Corp holds a...
- This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency. The $15,576.78 contract is for the supply of a diabetes medication, Liraglutide 3-Pak 18 mg/3 mL 3mL. The order has a completion date of May 7, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a substantial Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical, which enables the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Liraglutide 3-Pak 18 mg/3 ml pharmaceutical product with a ceiling value of $12,172.10. This firm fixed-price delivery order is scheduled for completion by August 29, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation and represents a child contract under...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,405.49, is for the delivery of Liraglutide 3-Pak 18 mg/3 ml 3 ml, a medication used to treat diabetes. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,253.88 to AmerisourceBergen Drug Corp for Liraglutide 3-Pak 18 mg/3 ml pharmaceutical product. This non-set-aside, firm fixed-price delivery order was awarded on August 28, 2025, with an ultimate completion date of August 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor...